Peripheral Intravenous Catheter Market Growth, Analysis, Trends and Forecast to 2032

The global peripheral intravenous catheters market is expected to grow steadily at a rate of 7.2% YoY, reaching a valuation of US$ 11.03 billion by 2032. The increasing acceptance of catheterisation techniques for diagnosis, examination, and treatment of patients is projected to drive the demand for PIVC. The North American market is likely to remain the largest market, while the Asia Pacific market is expected to grow at the fastest pace.

The rising incidence of diseases is a significant factor driving the demand for catheterisation and PIVC. Besides drug administration, the use of PIVC in body fluid collection during physical examinations is also identified as a key driver of market growth. The prevalence of infections and epidemics is expected to further increase demand for catheters across hospitals, clinics, ambulatory surgical centers, home healthcare units, and other healthcare facilities.

Increasing investments in healthcare infrastructure, as well as rising healthcare spending by consumers, are expected to support market growth. Technological advancements in PIVC are also likely to have a positive impact on sales, with PIVC being considered a superior option to other types of catheters. Therefore, PIVC is expected to continue to be the preferred choice and support market growth.

Some of the leading players in peripheral intravenous catheter market include:

  • Becton, Dickinson and Company
  • B. Braun Melsungen AG
  • Smiths Group plc.
  • Terumo Corporation
  • Venner Medical
  • Vygon
  • Teleflex Incorporated
  • C. R. Bard, Inc.
  • NIPRO Medical Corporation
  • Argon Medical Devices, Inc

Read More@ https://www.futuremarketinsights.com/reports/peripheral-intravenous-catheter-market

By Product Type:

  • Short Peripheral IV Catheter
    • Ported PIVC
    • Non-Ported PIVC
  • Integrated/Closed PIVC
    • Closed with Extension Sets
    • Closed PIVC

By Technology:

  • Conventional PIVC
  • Safety PIVC
    • Closed with Extension Set
    • Active PIVC with Blood Control
    • Passive PIVC with Blood Control
    • Active PIVC
    • Passive PIVC

By End User:

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Clinics
  • Home Use
  • Others

Comments

Post a Comment

Popular posts from this blog

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

A Safer Tomorrow | Emerging Trends in Hospital-Acquired Infection Control Market

Image
According to Future Market Insights' recently released Hospital-acquired Infection Control Market analysis report, global Hospital-acquired Infection Control sales in 2023 are expected to be US$ 6.5 billion. The market is expected to increase at a CAGR of 7% between 2023 and 2033, reaching $12.7 billion by 2033. Hospitals and intensive care units are predicted to create significant income in the market, with a CAGR of 7.6%. The occurrence of hospital-acquired infections, increasing proportion of surgical procedures, growing geriatric population and increasing prevalence of chronic diseases, technological advancements in sterilisation equipment, and growing awareness of environmental and personal hygiene are the key factors driving the Hospital-acquired infection control market. The increased use of e-beam sterilisation, as well as the reintroduction of ethylene oxide sterilisation, is predicted to increase demand for hospital-acquired infection management. The percentage of treatm
Read more

Transforming Trauma | Emerging Therapies and Interventions in Post-Traumatic Stress Disorder Treatment Market

Image
According to Future Market Insights, the Post-Traumatic Stress Disorder (PTSD) Treatment Market Sales would grow at a 5% CAGR between 2023 and 2033. By 2033, the global market for post-traumatic stress disorder (PTSD) therapy is expected to reach US$ 27.37 billion. The market's growth might be attributed to the increased prevalence of PTSD globally. According to the National Centre for PTSD, approximately 7-8% of the US population will develop PTSD at some point in their lives, with greater percentages among military veterans and persons who have experienced sexual assault or other types of trauma. The COVID-19 pandemic has also been highlighted as a possible cause of PTSD, with healthcare workers, first responders, and people immediately impacted by the virus being especially vulnerable. In addition, there is a growing emphasis on using digital therapies and other non-pharmacological techniques to treat PTSD. For example, virtual reality exposure treatment (VRET) has shown potent
Read more